HALOZYME THERAPEUTICS, INCHALOZYME THERAPEUTICS, INCHALOZYME THERAPEUTICS, INC

HALOZYME THERAPEUTICS, INC

No trades
See on Supercharts

Price target

1,275.050.000.00%
The 9 analysts offering 1 year price forecasts for HALO have a max estimate of — and a min estimate of —.

Analyst rating

Based on 11 analysts giving stock ratings to HALO in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


HALO EPS for the last quarter is 25.02 MXN despite the estimation of 18.88 MXN. In the next quarter EPS is expected to reach 23.96 MXN. Track more of HALOZYME THERAPEUTICS, INC financials and stay on top of what is up with the company.
In the next quarter HALOZYME THERAPEUTICS, INC revenue is expected to reach ‪6.00 B‬ MXN. Check out HALOZYME THERAPEUTICS, INC revenue and earnings and make informed decisions.
According to analysts, HALO price target is 1,275.05 MXN with a max estimate of 1,531.42 MXN and a min estimate of 1,020.95 MXN. Check if this forecast comes true in a year, meanwhile watch HALOZYME THERAPEUTICS, INC stock price chart and keep track of the current situation with HALO news and stock market news.
We've gathered opinions of 11 analysts rating HALO stock in the past 3 months. After counting all points of view, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.